Apollo Endosurgery Inc EBITDA margin
What is the EBITDA margin of Apollo Endosurgery Inc?
The EBITDA margin of Apollo Endosurgery Inc is -60.86%
What is the definition of EBITDA margin?
EBITDA margin is a profitability ratio that measures how much EBITDA the company generates as a percentage of revenue.
ttm (trailing twelve months)
EBITDA margin measures how much of EBITDA is generated as a percentage of sales. It measures the company’s operating profit as a percentage of its revenue and is calculated as EBITDA (earnings before interest, taxes, depreciation, and amortization) divided by total revenue.
EBITDA margin also helps with judging the effectiveness of cost-cutting processes at the company. The higher the company’s EBITDA margin, the lower operating expenses are in respect to revenue. As a result, a higher EBITDA margin is considered more favorable. Smaller companies can have higher EBITDA margins since they are able to operate more efficiently and maximize their profitability.
EBITDA excludes interest on debt, taxes, and capital expenditures, the margin does not provide a perfectly clear estimate of the business’s cash flow generation. Furthermore, EBITDA margin is not recognized as a GAAP (generally accepted accounting principles) metric.
EBITDA margin of companies in the Health Care sector on NASDAQ compared to Apollo Endosurgery Inc
What does Apollo Endosurgery Inc do?
Apollo Endosurgery, Inc. is a medical technology company focused on less invasive therapies to treat various gastrointestinal conditions, ranging from gastrointestinal defect repairs to the interventional treatment of obesity. Apollo's device-based therapies are an alternative to invasive surgical procedures, thus lowering complication rates and reducing total healthcare costs. Apollo's products are offered in over 75 countries today and include the X-Tack™ Endoscopic HeliX Tacking System, the OverStitch™ Endoscopic Suturing System, the OverStitch Sx™ Endoscopic Suturing System, and the ORBERA® Intragastric Balloon.
Companies with ebitda margin similar to Apollo Endosurgery Inc
- Megalith has EBITDA margin of -61.33%
- Sailfish Royalty has EBITDA margin of -61.30%
- Echo Plc has EBITDA margin of -61.25%
- Avita Medical has EBITDA margin of -61.20%
- Hutchison China MediTech has EBITDA margin of -61.12%
- Tu Yi has EBITDA margin of -60.99%
- Apollo Endosurgery Inc has EBITDA margin of -60.86%
- Aurinia Pharmaceuticals has EBITDA margin of -60.84%
- Hostelworld plc has EBITDA margin of -60.83%
- Taal Distributed Information Technologies has EBITDA margin of -60.81%
- Weimob has EBITDA margin of -60.69%
- Cluey Ltd has EBITDA margin of -60.68%
- Waterdrop has EBITDA margin of -60.59%